首页> 美国卫生研究院文献>International Journal of Hematology-Oncology and Stem Cell Research >Human Platelet Lysate as a Xeno Free Alternative of Fetal Bovine Serum for the In Vitro Expansion of Human Mesenchymal Stromal Cells
【2h】

Human Platelet Lysate as a Xeno Free Alternative of Fetal Bovine Serum for the In Vitro Expansion of Human Mesenchymal Stromal Cells

机译:人血小板裂解物作为人牛间质基质细胞体外扩增的胎牛血清的异种免费替代品。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Mesenchymal stromal cells (MSCs) are employed in various different clinical settings in order to modulate immune response. Human autologous and allogeneic supplements including platelet derivatives such as platelet lysate (PL), platelet-released factors (PRF) and serum are assessed in clinical studies to replace fetal bovine serum (FBS). The immunosuppressive activity and multi-potential characteristic of MSCs appear to be maintained when the cells are expanded in platelet derivatives. Materials and Methods: Platelet-rich plasma was collected from umbrical cord blood (UCB). Platelet-derived growth factors obtained by freeze and thaw methods. CD62P expression was determined by flow cytometry. The concentration of PDGF-BB and PDGF-AB was detemined by ELISA. We tested the ability of a different concentration of PL-supplemented medium to support the ex vivo expansion of Wharton's jelly derived MSCs. We also investigated the biological/functional properties of expanded MSCs in presence of different concentration of PL. The conventional karyotyping was performed in order to study the chromosomal stability. The gene expression of Collagen I and II aggrecan and SOX-9 in the presence of different concentrations of PL was evaluated by Real-time PCR. Results: We observed 5% and 10% PL, causing greater effects on proliferation of MSCs .These cells exhibited typical morphology, immunophenotype and differentiation capacity. The genetic stability of these derivative cells from Wharton's jelly was demonstrated by a normal karyotype. Furthermore, the results of Real-time PCR analysis showed that the expression of chondrocyte specific genes was higher in MSCs in the presence of 5% and 10% PL, compared with FBS supplement. Conclusions: We demonstrated that PL could be used as an alternative safe source of growth factors for expansion of MSCs and also maintained similar growing potential and phenotype without any effect on chromosomal stability.
机译:背景:间质基质细胞(MSCs)用于各种不同的临床环境,以调节免疫应答。在临床研究中评估了人类自体和同种异体补品,包括血小板衍生物,如血小板溶解物(PL),血小板释放因子(PRF)和血清,以替代胎牛血清(FBS)。当细胞在血小板衍生物中扩增时,似乎保持了MSC的免疫抑制活性和多电势特征。 材料和方法:从脐带血(UCB)收集富含血小板的血浆。通过冷冻和融化方法获得的血小板衍生生长因子。通过流式细胞术确定CD62P表达。通过ELISA确定PDGF-BB和PDGF-AB的浓度。我们测试了不同浓度的补充PL的培养基支持Wharton's果冻来源的MSC体外离体扩增的能力。我们还研究了存在不同浓度PL时扩增的MSC的生物学/功能特性。为了研究染色体的稳定性,进行了常规的核型分析。通过实时荧光定量PCR(Real-time PCR)评估胶原蛋白I和II的聚集蛋白聚糖和SOX-9在不同浓度的PL存在下的基因表达。 结果:我们观察到5%和10%的PL,对MSC的增殖产生更大的影响。这些细胞表现出典型的形态,免疫表型和分化能力。这些来自沃顿氏胶的衍生细胞的遗传稳定性通过正常的核型得到证实。此外,实时PCR分析的结果表明,与FBS补充剂相比,在存在5%和10%PL的情况下,MSC中软骨细胞特异性基因的表达更高。 结论:我们证明了PL可以用作MSC扩增的替代安全生长因子来源,并且可以保持相似的生长潜力和表型,而对染色体稳定性没有任何影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号